
NextMed is a leading provider of patient-centered lithotripsy services in the U.S., founded in 1996. The company focuses on delivering the highest success rates in kidney stone treatment through innovative technologies and data-driven research. With a national presence serving over 400 facilities and 1000 physicians, NextMed differentiates itself by utilizing advanced technology and a robust quality improvement program. Their mission is to revolutionize healthcare by providing unsurpassed urological services, ensuring the best treatment outcomes for patients and physicians alike.

NextMed is a leading provider of patient-centered lithotripsy services in the U.S., founded in 1996. The company focuses on delivering the highest success rates in kidney stone treatment through innovative technologies and data-driven research. With a national presence serving over 400 facilities and 1000 physicians, NextMed differentiates itself by utilizing advanced technology and a robust quality improvement program. Their mission is to revolutionize healthcare by providing unsurpassed urological services, ensuring the best treatment outcomes for patients and physicians alike.
Industry: Urology - lithotripsy services
Founded: 1996
Headquarters: Tucson, AZ
Scale: Serves ~400 facilities and 1000+ physicians; ~185 employees
Clinical signal: Claims high success rates and HFAP Comprehensive Lithotripsy/Laser certification
Improving access, outcomes, and efficiency of kidney stone treatment for patients and urology providers.
1996
Healthcare
Total Funding: 170000.00 USD